Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SIS | Toronto | CAD | Real-time | |
SIS | CBOE Canada | CAD | Real-time |
For the three months ended 31 March 2022, Savaria Corporation revenues increased 64% to C$183.5M. Net income increased 40% to C$5.3M. Revenues reflect Accessibility segment increase of 62% to C$130.3M, Patient Handling segment increase of 63% to C$41.7M, Europe segment increase of 85% to C$46.1M, United States segment increase of 23% to C$62.4M.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 183.54 | 189.53 | 180.76 | 178.62 |
Gross Profit | 58.52 | 59.82 | 58.51 | 65.23 |
Operating Income | 8.83 | -3.42 | 16.02 | 14.71 |
Net Income | 5.35 | -9.81 | 9.12 | 6.59 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 1072.21 | 1106.92 | 1064.11 | 1069.84 |
Total Liabilities | 650.43 | 672.32 | 611.27 | 618.76 |
Total Equity | 421.77 | 434.6 | 452.84 | 451.08 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 13 | 57.28 | 50.06 | 42.33 |
Cash From Investing Activities | -4.81 | -396.44 | -393.21 | -369.31 |
Cash From Financing Activities | -27.15 | 351.8 | 357.55 | 363.42 |
Net Change in Cash | -19.59 | 9.31 | 10.94 | 33.61 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review